BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29959659)

  • 1. Fumaric acid: a possible new therapy for macular edema?
    Kofler L; Kathrein-Schneider S; Schweinzer K; Kofler H
    Int Ophthalmol; 2019 Jul; 39(7):1627-1631. PubMed ID: 29959659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical Coherence Tomography Angiography in Macular Edema.
    Lupidi M; Coscas F; Cagini C; Coscas G
    Dev Ophthalmol; 2017; 58():63-73. PubMed ID: 28351045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Biometry Derived Axial Length Measurements Following Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema.
    Kymionis GD; Giarmoukakis A; Apostolidi IK; Blazaki SV; Tsoulnaras KI; Moschandrea J; Panagopoulou S; Tsilimbaris MK
    Semin Ophthalmol; 2018; 33(4):488-491. PubMed ID: 28402713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.
    Lee YJ; Kim M
    Korean J Ophthalmol; 2019 Apr; 33(2):198-199. PubMed ID: 30977331
    [No Abstract]   [Full Text] [Related]  

  • 6. Macular Telangiectasia Type 1 Managed With Long-Term Aflibercept Therapy.
    Kovach JL; Hess H; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):593-5. PubMed ID: 27327292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular edema. Diagnosis and detection.
    Staurenghi G; Invernizzi A; de Polo L; Pellegrini M
    Dev Ophthalmol; 2010; 47():27-48. PubMed ID: 20703042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
    Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
    Osaka R; Muraoka Y; Miwa Y; Manabe K; Kobayashi M; Takasago Y; Ooto S; Murakami T; Suzuma K; Iida Y; Tsujikawa A
    Ophthalmologica; 2018; 239(1):27-35. PubMed ID: 28946138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
    Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Detection.
    Staurenghi G; Pellegrini M; Invernizzi A; Preziosa C
    Dev Ophthalmol; 2017; 58():39-62. PubMed ID: 28351044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroretinal Imaging Inflammatory Biomarkers Anticipating Radiation-Induced Macular Edema.
    Parrozzani R; Midena E; Bini S; Frizziero L
    Retina; 2019 Oct; 39(10):e45-e46. PubMed ID: 31568188
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic and Therapeutic Challenges.
    Agarwal M; Mayor R; Ranjan R; Kokame GT
    Retina; 2019 Jun; 39(6):1225-1229. PubMed ID: 29746408
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystoid macular edema in a child.
    Hamburger J; Yang X; Shields CL
    Indian J Ophthalmol; 2020 Mar; 68(3):419. PubMed ID: 32056992
    [No Abstract]   [Full Text] [Related]  

  • 16. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
    Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Edema: Definition and Basic Concepts.
    Coscas G; Cunha-Vaz J; Soubrane G
    Dev Ophthalmol; 2017; 58():1-10. PubMed ID: 28351040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging in dominant cystoid macular dystrophy.
    Roy R; Saurabh K; Bhattacharyya S; Thomas NR; Datta K
    Indian J Ophthalmol; 2017 Sep; 65(9):865-866. PubMed ID: 28905832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.